AFP and hepatocellular carcinoma: However, the positive rate of serum CNN2 antibody in HCC was not related to clinical indicators such as age, sex, AFP value, BCLC stage, cirrhosis, ALT value, AST value, HBsAg, tumor size, etc. These results are consistent with our SEREX research results.